Free Trial

Direxion Daily S&P Biotech Bull 3x Shares (LABU) Holdings

→ My system predicted the BA collapse – now it’s issuing an AI warning (From Chaikin Analytics) (Ad)
Free LABU Stock Alerts
$110.90
+3.09 (+2.87%)
(As of 05/14/2024 ET)
Compare
Stock AnalysisChartHeadlinesHoldingsOwnershipRatings

Top 50 LABU Holdings

RankCompanyCurrent PriceWeightShares Held
1S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPN/A44.47%64,102
2S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPN/A42.41%61,129
3S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPN/A38.65%55,710
4S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPN/A38.55%55,572
5DREYFUS GOVT CASH MAN INSN/A28.07%266,419,899
6S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPN/A26.03%37,527
7S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPN/A22.64%32,629
8S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX SWAPN/A20.97%30,234
9GOLDMAN FINL SQ TRSRY INST 506N/A11.26%106,903,532
10DREYFUS TRSRY SECURITIES CASH MGMTN/A1.95%18,470,000
11
Alpine Immune Sciences, Inc. stock logo
ALPN
Alpine Immune Sciences
$64.95
1.25%183,314
12GOLDMAN SACHS FIN GOV 465 INSTITUTN/A0.90%8,540,000
13
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$37.38
+0.6%		0.87%222,169
14
ImmunityBio, Inc. stock logo
IBRX
ImmunityBio
$8.40
-2.7%		0.86%1,023,817
15
Viking Therapeutics, Inc. stock logo
VKTX
Viking Therapeutics
$72.50
+0.2%		0.84%99,821
16
Moderna, Inc. stock logo
MRNA
Moderna
$128.32
+2.1%		0.81%69,547
17
Exelixis, Inc. stock logo
EXEL
Exelixis
$20.99
-1.3%		0.80%322,599
18
Natera, Inc. stock logo
NTRA
Natera
$105.52
+2.1%		0.79%80,458
19
Cerevel Therapeutics Holdings, Inc. stock logo
CERE
Cerevel Therapeutics
$42.24
+0.4%		0.78%173,690
20
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
$49.38
+3.0%		0.78%169,426
21
Geron Co. stock logo
GERN
Geron
$3.68
-1.6%		0.78%1,883,893
22
PTC Therapeutics, Inc. stock logo
PTCT
PTC Therapeutics
$31.18
-1.6%		0.78%229,945
23
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$11.33
+1.3%		0.77%670,870
24
Sarepta Therapeutics, Inc. stock logo
SRPT
Sarepta Therapeutics
$132.66
+0.7%		0.77%57,612
25
Amgen Inc. stock logo
AMGN
Amgen
$311.41
+1.0%		0.76%26,175
26
Blueprint Medicines Co. stock logo
BPMC
Blueprint Medicines
$105.46
-2.4%		0.75%77,626
27
Exact Sciences Co. stock logo
EXAS
Exact Sciences
$54.00
-2.9%		0.75%119,342
28
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$138.48
+1.7%		0.75%51,460
29
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$147.89
-1.3%		0.73%47,821
30
Biogen Inc. stock logo
BIIB
Biogen
$226.88
+0.7%		0.73%32,094
31
United Therapeutics Co. stock logo
UTHR
United Therapeutics
$269.78
+2.1%		0.73%29,480
32
Dyne Therapeutics, Inc. stock logo
DYN
Dyne Therapeutics
$28.16
+5.8%		0.72%269,070
33
Rhythm Pharmaceuticals, Inc. stock logo
RYTM
Rhythm Pharmaceuticals
$40.38
+0.4%		0.72%170,832
34
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$428.59
-0.3%		0.72%17,320
35
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$79.65
-1.1%		0.71%83,367
36
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$38.27
-1.4%		0.71%162,875
37
Cytokinetics, Incorporated stock logo
CYTK
Cytokinetics
$59.36
+2.5%		0.70%108,974
38
AbbVie Inc. stock logo
ABBV
AbbVie
$161.55
+0.2%		0.69%40,057
39
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$43.82
+0.5%		0.69%171,693
40
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$984.64
+0.8%		0.69%7,396
Elon Musk’s Next Move Will Disrupt AI Forever (Ad)

A revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.

Get all the information here.
41
SpringWorks Therapeutics, Inc. stock logo
SWTX
SpringWorks Therapeutics
$42.95
+3.7%		0.69%140,299
42
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$28.95
+1.6%		0.67%247,235
43
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$41.80
+1.8%		0.67%157,273
44
Insmed Incorporated stock logo
INSM
Insmed
$25.45
-1.5%		0.67%257,545
45
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$159.47
+3.0%		0.67%41,703
46
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$67.65
+0.2%		0.66%95,386
47
Dynavax Technologies Co. stock logo
DVAX
Dynavax Technologies
$11.00
-0.3%		0.65%545,277
48
Immunovant, Inc. stock logo
IMVT
Immunovant
$30.48
+2.0%		0.65%226,093
49
Incyte Co. stock logo
INCY
Incyte
$57.05
-1.0%		0.65%119,377
50
Vericel Co. stock logo
VCEL
Vericel
$48.53
+0.0%		0.65%134,669

Geographic Exposure

  • United States
    56.0%
  • Ireland
    1.0%
  • Bermuda
    0.7%
  • Switzerland
    0.4%
  • Virgin Islands, British
    0.4%

Currency Exposure

  • USD
    316.8%

Sector Exposure

  • Health Care
    38.4%
  • Consumer Discretionary
    1.2%
  • Energy
    0.5%

Industry Exposure

  • Biotechnology
    35.1%
  • Health Care Equipment & Supplies
    2.6%
  • Diversified Consumer Services
    0.8%
  • Health Care Providers & Services
    0.7%
  • Renewable Energy
    0.5%
  • Distributors
    0.4%

SubIndustry Exposure

  • Biotechnology
    33.1%
  • Life Sciences Tools & Services
    2.1%
  • Pharmaceuticals
    1.0%
  • Health Care Services
    0.7%
  • Renewable Energy Equipment
    0.5%
  • Health Care Equipment
    0.4%
  • Health Care Supplies
    0.2%

Coupon Exposure

  • 4-6
    37.0%

Maturity Exposure

  • 20-30
    219.0%

Related Companies and Tools

Related Companies:
This page (NYSEARCA:LABU) was last updated on 5/14/2024 by MarketBeat.com Staff

From Our Partners
Did Intel Just Dethrone Nvidia?
Chaikin Analytics
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Charles Payne Demystifies Options
Unstoppable Prosperity
Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way
Small Cap Sniper
Crypto Millionaire Says: “Buy This $11 AI Coin.”
InvestorPlace
The only AI company you should be looking at
Behind the Markets